Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity

scientific article published on November 2006

Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/JM0606138
P698PubMed publication ID17064073

P2093author name stringChristine Lukacs
Nan Jiang
Kathryn Packman
Allen Lovey
Xuefeng Yin
Nader Fotouhi
Melissa A Smith
Sung-Sau So
Qing Xiang
Yingsi Chen
Petra Goelzer
Ka Wang
Bradford Graves
David Bartkovitz
Qingjie Ding
Xin-Jie Chu
Binh T Vu
Wanda DePinto
Gerald Kaplan
John Moliterni
Brian X Higgins
P433issue22
P407language of work or nameEnglishQ1860
P304page(s)6549-6560
P577publication date2006-11-01
P1433published inJournal of Medicinal ChemistryQ900316
P1476titleDiscovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity
P478volume49